| Typicality: | 0.523 |
| Saliency: | 0.259 |
| in the annual exacerbation rate ratio | 10 | other |
| statistically | 6 | manner |
| compared with placebo | 5 | other |
| subject → have → significant reduction | 15 |
| subject → have → significant reductions | 7 |
| negative | neutral | positive |
| 0.032 | 0.618 | 0.350 |
| Raw frequency | 22 |
| Normalized frequency | 0.259 |
| Modifier score | 1.000 |
| Perplexity | 60.477 |